$RNTX gets FDA Fast Track status for LTI-03. Not an approval—watch the Phase 2 interim data expected in 2H 2026.
#Biotech #Biotechnology #Health #HealthInnovation #Therapeutics
Disclaimer: This is NOT a financial advice
$RNTX gets FDA Fast Track status for LTI-03. Not an approval—watch the Phase 2 interim data expected in 2H 2026. #Biotech #Biotechnology #Health #HealthInnovation #Therapeutics Disclaimer: This is NOT a financial advice
0 views
Published on 25/08/2026 06:12
$RNTX gets FDA Fast Track status for LTI-03. Not an approval—watch the Phase 2 interim data expected in 2H 2026.
#Biotech #Biotechnology #Health #HealthInnovation #Therapeutics
Disclaimer: This is NOT a financial advice
0 comments
?